[1] |
Xu Y, Wang L, He J, et al. Prevalence and control of diabetes in Chinese adults[J]. JAMA, 2013, 310(9):948-959.
|
[2] |
Watt KD, Charlton MR. Metabolic syndrome and liver transplantation: a review and guide to management[J]. J Hepatol, 2010, 53(1):199-206.
|
[3] |
Parekh J, Corley DA, Feng S. Diabetes, hypertension and hyperlipidemia: prevalence over time and impact on long-term survival after liver transplantation[J]. Am J Transplant, 2012, 12(8):2181-2187.
|
[4] |
Zhao J, Wang F, Zhang Y, et al. Sevoflurane preconditioning attenuates myocardial ischemia/reperfusion injury via caveolin-3-dependent cyclooxygenase-2 inhibition[J]. Circulation, 2013, 128(11 Suppl 1):S121-129.
|
[5] |
Lurati Buse GA, Schumacher P, Seeberger E, et al. Randomized comparison of sevoflurane versus propofol to reduce perioperative myocardial ischemia in patients undergoing noncardiac surgery[J]. Circulation, 2012, 126(23):2696-2704.
|
[6] |
Zhou SP, Jiang P, Liu L, et al. Protective effect of sevoflurane on hepatic ischaemia/reperfusion injury in the rat: a dose-response study[J]. Eur J Anaesthesiol, 2013, 30(10):612-617.
|
[7] |
周少朋,张雪霞,候冰宗,等.七氟醚预处理对大鼠肝脏缺血再灌注损伤的影响[J/CD].消化肿瘤杂志(电子版),2011,3(1):45-48.
|
[8] |
张南文,吴伟芳,林剑鸣.不同浓度水合氯醛在两种雄性小鼠麻醉中的应用[J].临床麻醉学杂志,2014,30(2):171-173.
|
[9] |
Yamada F, Saito T, Abe T, et al. Ischemic preconditioning enhances regenerative capacity of hepatocytes in long-term ischemically damaged rat livers[J]. J Gastroenterol Hepatol, 2007, 22(11):1971-1977.
|
[10] |
Gujral JS, Bucci TJ, Farhood A, et al. Mechanism of cell death during warm hepatic ischemia-reperfusion in rats: apoptosis or necrosis?[J]. Hepatology, 2001, 33(2):397-405.
|
[11] |
Penna C, Mancardi D, Rastaldo R, et al. Cardioprotection: a radical view free radicals in pre and postconditioning[J]. Biochim Biophys Acta, 2009, 1787(7):781-793.
|
[12] |
Karatzas T, Neri AA, Baibaki ME, et al. Rodent models of hepatic ischemia-reperfusion injury: time and percentage-related pathophysiological mechanisms[J]. J Surg Res, 2014, 191(2):399-412.
|
[13] |
谢汉镔,葛缅,池信锦,等.肝移植围手术期缺血-再灌注胃氧化损伤发生机制[J/CD].中华肝脏外科手术学电子杂志,2015,4(4):254-258.
|
[14] |
Romanque UP, Uribe MM, Videla LA. Molecular mechanisms in liver ischemic-reperfusion injury and ischemic preconditioning[J]. Rev Med Chil, 2005, 133(4):469-476.
|
[15] |
Luedde T, Liedtke C, Manns MP, et al. Losing balance: cytokine signaling and cell death in the context of hepatocyte injury and hepatic failure[J]. Eur Cytokine Netw, 2002, 13(4):377-383.
|
[16] |
Cutrin JC, Boveris A, Zingaro B, et al. In situ determination by surface chemiluminescence of temporal relationships between evolving warm ischemia-reperfusion injury in rat liver and phagocyte activation and recruitment[J]. Hepatology, 2000, 31(3):622-632.
|
[17] |
Hisama N, Yamaguchi Y, Ishiko T, et al. Kupffer cell production of cytokine-induced neutrophil chemoattractant following ischemia/reperfusion injury in rats[J]. Hepatology, 1996, 24(5):1193-1198.
|
[18] |
El-Wahsh M, Seifalian AM, Fuller BJ, et al. Induction of adhesion molecule expression in liver ischaemia-reperfusion injury is associated with impaired hepatic parenchymal microcirculation[J]. Br J Surg, 2004, 91(8):1034-1039.
|
[19] |
Zheng J, Wang WL. Risk factors of metabolic syndrome after liver transplantation[J]. Hepatobiliary Pancreat Dis Int, 2015, 14(6):582-587.
|
[20] |
Meng GX, Yuan Q, Wei LP, et al. Protein kinase C-beta inhibitor treatment attenuates hepatic ischemia and reperfusion injury in diabetic rats[J]. Exp Ther Med, 2016, 11(2):565-570.
|